Results 71 to 80 of about 27,956 (253)
Physical Limitations of Scleroderma- A Personal Perspective
Scleroderma, like many misunderstood chronic diseases, put a tremendous burden on both the patient and their family. In this deeply personal narrative, the first author describes the impact of scleroderma on her family.
Reema Adusumilli, Sydney Vaughn
openaire +1 more source
Objective Interstitial lung disease (ILD) is an important extra‐articular manifestation of rheumatoid arthritis (RA) associated with high mortality and morbidity. Lung ultrasonography (LUS) has recently emerged as a possible screening tool. We assessed the role of LUS in monitoring radiologic progression and the development of new interstitial lung ...
Marie Vermant +15 more
wiley +1 more source
Optimization of Scleroderma spore inoculum for Eucalyptus nurseries in China
Scleroderma, a genus of ectomycorrhizal (ECM) fungi, is often associated with trees in disturbed habitats and is therefore considered to be suitable for use in plantation forestry.
Chen, Yinglong
core
Treatment of scleroderma by TCM
Scleroderma is a rare persistent hardening and contraction of the body’s connective tissue, which often affect any organ, including the skin, heart, kidney, lung or oesophageal.
Yang Xiang (35912)
core +1 more source
Collalysin in therapy of patients with limited scleroderma
In the pathogenesis of scleroderma an essential role is played by intensive collagen biosynthesis, which causes the development of fibrotic-sclerotic lesions. In this connection, it is pathogenetically substantiated the use of agents, the effect of which is aimed at decreasing the synthesis and increasing the catabolism of collagen.
openaire +1 more source
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia +16 more
wiley +1 more source
Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo +7 more
wiley +1 more source
Scleroderma (systemic sclerosis) is a complex disease in which extensive fibrosis, vascular alterations, and autoantibodies against various cellular antigens are among the principal features There are two major subgroups in the commonly accepted ...
Gabrielli A. +4 more
core
Dental implants and scleroderma
Scleroderma or systemic sclerosis is an autoimmune multisystem rheumatic ailment that impacts on connective tissues.this condition is characterized by fibrosis of the skin and can develop in the heart, lungs, kidneys, and gastrointestinal tract.(https ...
yasaman salimi, Seyed Ali Mosaddad
core +1 more source
Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome
Abstract Cite this article as: Düzgün N. Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome. Eur J Rheumatol 2017; 4: 305-6.
openaire +2 more sources

